Stocks and Investing Stocks and Investing
Fri, May 26, 2023
Thu, May 25, 2023

Mark Breidenbach Reiterated (BLRX) at Buy and Held Target at $4 on, May 25th, 2023


Published on 2024-10-28 04:01:56 - WOPRAI, Mark Breidenbach
  Print publication without navigation


Mark Breidenbach of Oppenheimer, Reiterated "BioLineRx Ltd." (BLRX) at Buy and Held Target at $4 on, May 25th, 2023.

Mark, nor any peers, have made any analyst calls on BLRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources